OnaWave Medical is a west of Ireland medtech company working to improve the diagnosis and treatment of pelvic conditions globally. Project EndoSolve supports the development of a digital biomarker-based risk-stratification platform with associated wearable solutions that can identify patients with pelvic conditions, such as endometriosis and subfertility, to support clinical decision-making and enhance the delivery of personalised care for the individual. This technology is patent pending. Project EndoSolve is supported by the European Innovation Council.
Hormonal Health lies at the heart of precision medicine. Long overlooked, the hormonal cycle in males and females is a personalized marker of health across our lifetime. OnaWave Medical’s mission is to revolutionize pelvic healthcare by harnessing the power of biological activity and digital technology. Our aim is to provide earlier, more accurate diagnoses and effective non-invasive treatments for chronic hormonal conditions through innovative medical devices.
OnaWave Medical is looking to develop partnerships to accelerate development of our technology (clinicians/policy-makers/technologists/strategics) to reach patients globally.
